Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 64 (representing 27 labs)

Tests names and labsConditionsGenes and analytesMethods

Parkinsons disease panel

Centogene AG - the Rare Disease Company
Germany
2830
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
7861205
  • C Sequence analysis of the entire coding region

Dementia, frontotemporal

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Frontotemporal Dementia w/ Parkinsonism (FTDP) - MAPT Gene

Center for Genetics at Saint Francis Saint Francis Hospital
United States
11
  • C Sequence analysis of the entire coding region

Frontotemporal Dementia (FTDP) - MAPT Gene, Exon 10 Only

Center for Genetics at Saint Francis Saint Francis Hospital
United States
11
  • E Sequence analysis of select exons

Parkinson Disease Sequencing Panel

PreventionGenetics
United States
1716
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Dementia Sequencing Panel

PreventionGenetics
United States
1213
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Frontotemporal Dementia via the MAPT Gene

PreventionGenetics
United States
21
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

MAPT, GRN. MLPA testing

Instituto de Medicina Genomica
Spain
32
  • D Deletion/duplication analysis

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Sequencing Panel

PreventionGenetics
United States
1721
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

MAPT. Sequencing of the exons 1, 9, 10, 11, 12 and 13

Instituto de Medicina Genomica
Spain
31
  • E Sequence analysis of select exons

MAPT. Sequencing of the exons 1, 9, 10, 11, 12 and 13

Instituto de Medicina Genomica
Spain
11
  • E Sequence analysis of select exons

MAPT. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

GRN, MAPT. MLPA testing (exons 1,3,6,10 and 12 gene GRN and exons 2 to 13 gene MAPT)

Instituto de Medicina Genomica
Spain
22
  • D Deletion/duplication analysis

MAPT. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

MAPT Mutation Analysis

Molecular Pathology Laboratory University of Pennsylvania Health System
United States
31
  • E Sequence analysis of select exons

Frontotemporal dementia

Labor Dr. Wisplinghoff
Germany
11
  • C Sequence analysis of the entire coding region

Dementia Panel

Blueprint Genetics
Finland
217
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Parkinson Disease Panel

Blueprint Genetics
Finland
112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neurogenetic Disorders - panels

Medizinisch Genetisches Zentrum München MGZ München
Germany
14597
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 64

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center